NEUROGATE: a new MR-compatible device for realizing minimally invasive treatment of intracerebral tumors.
The authors report on the handling and the practicability of a newly developed MR-compatible device, the NEUROGATE (Daum GmbH, Germany), which allows precise planning, simulation and control of stereotactic biopsy in patients with suspect intracranial lesions, and which allows minimally invasive maneuvers to be performed in a comfortable way. Twenty-eight patients were examined stereotactically in the Signa SP interventional 0.5 Tesla MRI (General Electric Medical Systems, USA), including 15 patients with malignant intracerebral tumors and poor general medical conditions (8 gliomas, 7 metastases) who were treated by laser-induced interstitial thermotherapy (LITT) after definite intraoperative neuropathological diagnosis. As a special stereotactic holding device, the NEUROGATE was favored as a reliable tool for stereotaxy and minimally invasive procedures.
Vitzthum
Hans Ekkehart
HE
Department of Neurosurgery, University of Leipzig, Leipzig, Germany. vithe@medizin.uni-leipzig.de
Winkler
Dirk
D
Strauss
Gero
G
Lindner
Dirk
D
Krupp
Wolfgang
W
Schneider
Jens Peter
JP
Schober
Ralf
R
Meixensberger
Jürgen
J
D000328:Adult; D000368:Aged; D001706:Biopsy / Q000295:instrumentation; D001932:Brain Neoplasms / Q000473:pathology / Q000556:secondary / Q000601:surgery*; D004867:Equipment Design; D005260:Female; D005910:Glioma / Q000473:pathology / Q000601:surgery*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D019060:Minimally Invasive Surgical Procedures / Q000295:instrumentation*; D038361:Neuronavigation / Q000295:instrumentation*; D015203:Reproducibility of Results